<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2026.1780562</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular mechanisms underlying <italic>Nocardia</italic> host interactions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Du</surname><given-names>Bingqian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1952234/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Song</surname><given-names>Ziyu</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3143492/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Yuan</surname><given-names>Min</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/375785/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Duan</surname><given-names>Yuting</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3402813/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Xu</surname><given-names>Shuai</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/549717/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Qiu</surname><given-names>Xiaotong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/702209/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Li</surname><given-names>Zhenjun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/671873/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention</institution>, <city>Beijing</city>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Wenzhou Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University</institution>, <city>Wenzhou</city>, <country country="cn">China</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University</institution>, <city>Nanjing</city>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Zhenjun Li, <email xlink:href="mailto:lizhenjun@icdc.cn">lizhenjun@icdc.cn</email></corresp>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-03-04">
<day>04</day>
<month>03</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>16</volume>
<elocation-id>1780562</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>02</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>09</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Du, Song, Yuan, Duan, Xu, Qiu and Li.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Du, Song, Yuan, Duan, Xu, Qiu and Li</copyright-holder>
<license>
<ali:license_ref start_date="2026-03-04">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p><italic>Nocardia</italic> species are opportunistic pathogens that cause localized and disseminated infections, particularly in immunocompromised individuals. Despite their clinical importance, the molecular mechanisms underlying <italic>Nocardia</italic> pathogenicity remain incompletely understood. This review summarizes current advances in <italic>Nocardia</italic> virulence factors, host immune responses, and intracellular survival strategies. A diverse array of virulence factors enables <italic>Nocardia</italic> to invade host cells, circumvent immune defenses, and maintain persistence within host tissues, including mammalian cell entry (Mce) proteins, antioxidant enzymes, phospholipase C, hemolysins, and siderophore-associated proteins. Host protection against <italic>Nocardia</italic> relies primarily on innate immune responses, with neutrophils playing a central role and being coordinated by &#x3b3;&#x3b4;T cells and interleukin-17&#x2013;mediated signaling pathways. In addition, the clinical epidemiology of nocardiosis and animal models of <italic>Nocardia</italic> infection are also briefly summarized. However, most mechanistic studies remain restricted to a limited number of type strains. Further investigations into <italic>Nocardia</italic>&#x2013;host interactions are essential for the development of improved diagnostic, therapeutic, and preventive strategies for nocardiosis.</p>
</abstract>
<kwd-group>
<kwd>animal models</kwd>
<kwd>host interactions</kwd>
<kwd>molecular mechanisms</kwd>
<kwd><italic>Nocardia</italic></kwd>
<kwd>virulence factors</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">
<institution-wrap>
<institution>National Key Research and Development Program of China</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100012166</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was supported by the National Key Research and Development Program of China (2024YFC2309300).</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="83"/>
<page-count count="9"/>
<word-count count="3633"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Bacteria and Host</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p><italic>Nocardia</italic> spp. are intracellular, facultatively aerobic, Gram-positive actinomycetes that are widely distributed in the natural environment (<xref ref-type="bibr" rid="B67">Traxler et&#xa0;al., 2022</xref>). They are capable of infecting both humans and animals, and can cause severe infections, including pulmonary, cutaneous, and cerebral abscesses, with a worldwide distribution (<xref ref-type="bibr" rid="B11">Chen et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B14">Du et al., 2025a</xref>; <xref ref-type="bibr" rid="B15">Du et al., 2025b</xref>; <xref ref-type="bibr" rid="B67">Traxler et&#xa0;al., 2022</xref>). In recent years, the incidence and detection rates of nocardiosis have increased steadily, leading to a growing global disease burden. Notably, the all-cause mortality associated with <italic>Nocardia</italic> infections has been reported to be as high as 19.8%, and mortality among patients with central nervous system (CNS) nocardiosis is even higher, reaching 20.3%-30.5% (<xref ref-type="bibr" rid="B15">Du et al., 2025b</xref>; <xref ref-type="bibr" rid="B57">Shen et&#xa0;al., 2025</xref>). Nocardiosis is considered an opportunistic infection that primarily affects immunocompromised individuals, such as solid organ transplant recipients receiving immunosuppressive therapy, patients with low CD4<sup>+</sup> T-lymphocyte counts, individuals with hematological malignancies, and those infected with human immunodeficiency virus (HIV) (<xref ref-type="bibr" rid="B18">Filice, 2005</xref>). Nevertheless, an increasing number of cases have also been documented in immunocompetent individuals, particularly among patients with bronchiectasis (<xref ref-type="bibr" rid="B78">Woodworth et&#xa0;al., 2017</xref>). The early diagnosis of nocardiosis remains challenging because of nonspecific clinical features, low bacterial burden, and difficulties in culture (<xref ref-type="bibr" rid="B67">Traxler et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B18">Filice, 2005</xref>). Therapeutic management is similarly difficult, often necessitating prolonged courses of antimicrobial therapy lasting several months or even years (<xref ref-type="bibr" rid="B77">Wilson, 2012</xref>; <xref ref-type="bibr" rid="B61">Song et&#xa0;al., 2025</xref>). Moreover, relapse is frequent, and the mortality rate remains high, especially among patients with underlying comorbidities (<xref ref-type="bibr" rid="B12">Coussement et&#xa0;al., 2016</xref>).</p>
<p>To date, most research on <italic>Nocardia</italic> has focused on clinical diagnosis and antimicrobial resistance, whereas the mechanisms governing host&#x2013;pathogen interactions remain poorly understood. In this review, we systematically summarize and integrate current knowledge on the clinical epidemiology of nocardiosis, experimental animal models of infection, host&#x2013;pathogen interaction mechanisms, and intracellular survival mechanisms of <italic>Nocardia</italic>. By synthesizing findings from clinical, microbiological, and immunological studies, this review aims to provide a more holistic understanding of <italic>Nocardia</italic> pathogenesis and to highlight key knowledge gaps that warrant further investigation.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Clinical features and epidemiology of nocardiosis</title>
<sec id="s2_1">
<label>2.1</label>
<title>Clinical features</title>
<p>Nocardiosis presents in three major clinical forms: primary cutaneous infection, pulmonary infection, and disseminated infection. Uncommon sites of infection or clinical features include bacteremia, ocular infection, CNS involvement, mycetoma, and other extrapulmonary infections (<xref ref-type="bibr" rid="B9">Brown-Elliott et&#xa0;al., 2006</xref>). Primary cutaneous nocardiosis typically results from the direct inoculation of <italic>Nocardia</italic> into the skin following trauma, such as puncture wounds sustained during gardening with exposure to <italic>Nocardia</italic>-contaminated soil, traumatic injuries associated with motor vehicle accidents involving soil or dust contamination, or infections acquired through nosocomial exposure (<xref ref-type="bibr" rid="B62">Steinbrink et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B65">Tarchini and Ross, 2013</xref>; <xref ref-type="bibr" rid="B76">Welsh et&#xa0;al., 2011</xref>). It has been reported that approximately 80% of <italic>Nocardia</italic> species causing primary cutaneous infections are <italic>N. brasiliensis</italic> (<xref ref-type="bibr" rid="B9">Brown-Elliott et&#xa0;al., 2006</xref>). The lungs are the most frequently affected site, with pulmonary involvement observed in approximately 66.7% of reported cases. Primary pulmonary nocardiosis is generally attributed to the inhalation of aerosolized <italic>Nocardia</italic> organisms or mycelia and occurs predominantly in patients with chronic lung disease, individuals receiving corticosteroid therapy, and immunocompromised population (<xref ref-type="bibr" rid="B15">Du et&#xa0;al., 2025b</xref>; <xref ref-type="bibr" rid="B43">McNeil and Brown, 1994</xref>; <xref ref-type="bibr" rid="B41">Maggiorelli et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B78">Woodworth et&#xa0;al., 2017</xref>). Clinical features of pulmonary nocardiosis are often nonspecific and include cough, dyspnea, fever, and pleuritic chest pain, making early diagnosis particularly challenging (<xref ref-type="bibr" rid="B67">Traxler et&#xa0;al., 2022</xref>). Disseminated nocardiosis may develop secondary to either primary cutaneous or pulmonary infection, with subsequent hematogenous spread to noncontiguous organs or systems. Common sites of dissemination include the CNS, kidneys, joints, retina, and heart (<xref ref-type="bibr" rid="B9">Brown-Elliott et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B5">Beaman and Beaman, 1994</xref>; <xref ref-type="bibr" rid="B57">Shen et&#xa0;al., 2025</xref>).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Epidemiology</title>
<p>To date, no national surveillance or mandatory reporting system for <italic>Nocardia</italic> infections has been established, which precludes accurate estimation of the true incidence of nocardiosis. Available epidemiological data indicate that the estimated incidence ranges from approximately 0.33-0.87 cases per 100,000 population in Canada (<xref ref-type="bibr" rid="B17">Exmelin et&#xa0;al., 1996</xref>), 0.23-0.46 cases per 100,000 in the United States (<xref ref-type="bibr" rid="B6">Beaman et&#xa0;al., 1976</xref>), 0.45 cases per 100,000 in Spain (<xref ref-type="bibr" rid="B82">Yong et&#xa0;al., 2015</xref>), and 0.04 cases per 100,000 in Germany (<xref ref-type="bibr" rid="B72">Vuotto et&#xa0;al., 2011</xref>). Notably, the incidence increases dramatically among immunocompromised populations (<xref ref-type="bibr" rid="B25">Harpaz et&#xa0;al., 2016</xref>). Reported prevalence rates among heart transplant recipients range from approximately 0.65% to 2.5% (<xref ref-type="bibr" rid="B55">Santos et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B49">Peleg et&#xa0;al., 2007</xref>), and may reach as high as 13% in patients receiving azathioprine-based immunosuppressive therapy (<xref ref-type="bibr" rid="B28">Hofflin et&#xa0;al., 1987</xref>). Santos et&#xa0;al. reported prevalence rates of approximately 1.78% in lung transplant recipients, 0.26% in kidney transplant recipients, and 0.18% in liver transplant recipients (<xref ref-type="bibr" rid="B55">Santos et&#xa0;al., 2011</xref>). A national surveillance study in France further demonstrated that nocardiosis occurred at a rate of approximately 60 cases per 100,000 among patients with cancer, with an even higher incidence of approximately 701 cases per 100,000 among bone marrow transplant recipients (<xref ref-type="bibr" rid="B66">Torres et&#xa0;al., 2002</xref>).</p>
<p>Nocardiosis is relatively uncommon in individuals with HIV infection, which may be attributable to the routine use of trimethoprim&#x2013;sulfamethoxazole prophylaxis for Pneumocystis Pneumonia; nevertheless, mortality among patients with HIV-associated nocardiosis remains high (<xref ref-type="bibr" rid="B38">Lederman and Crum, 2004</xref>; <xref ref-type="bibr" rid="B14">Du et&#xa0;al., 2025a</xref>). Moreover, although <italic>Nocardia</italic> species are distributed worldwide, substantial geographic variation in species prevalence has been observed (<xref ref-type="bibr" rid="B15">Du et&#xa0;al., 2025b</xref>). It should be emphasized that the high prevalence of <italic>N. asteroides</italic> reported in older literature should be interpreted with caution. Following the availability of molecular phylogenetic studies, strains previously typed as <italic>N. asteroides</italic> have been reclassified into distinct species, including <italic>N. cyriacigeorgica</italic>, <italic>N. nova</italic>, and <italic>N. abscessus</italic> (<xref ref-type="bibr" rid="B52">Roth et&#xa0;al., 2003</xref>). Therefore, many historical cases of <italic>N. asteroides</italic> likely represent these more accurately defined taxa. <italic>N. nova</italic> is the most frequently identified species in the United States (21.6-28%) (<xref ref-type="bibr" rid="B24">Hamdi et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B81">Yeoh et&#xa0;al., 2022</xref>) and Australia (29-35.5%) (<xref ref-type="bibr" rid="B81">Yeoh et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B75">Wei et&#xa0;al., 2021</xref>). In contrast, <italic>N. farcinica</italic> predominates in Belgium (44%) (<xref ref-type="bibr" rid="B70">Valdezate et&#xa0;al., 2017</xref>), China (29.1%) (<xref ref-type="bibr" rid="B73">Wang et&#xa0;al., 2023</xref>), South Africa (20.5%) (<xref ref-type="bibr" rid="B40">Lowman and Aithma, 2010</xref>), and France (20.2%) (<xref ref-type="bibr" rid="B37">Lebeaux et&#xa0;al., 2019</xref>), whereas <italic>N. cyriacigeorgica</italic> is most commonly reported in Iran (31.0%) (<xref ref-type="bibr" rid="B26">Hashemi-Shahraki et&#xa0;al., 2015</xref>), China (25.3%) (<xref ref-type="bibr" rid="B73">Wang et&#xa0;al., 2023</xref>), and Spain (25.3%) (<xref ref-type="bibr" rid="B70">Valdezate et&#xa0;al., 2017</xref>).</p>
</sec>
</sec>
<sec id="s3">
<label>3</label>
<title>Animal models of <italic>Nocardia</italic> infection</title>
<sec id="s3_1">
<label>3.1</label>
<title>Mice models</title>
<p>Animal models allow for reproducible assessment of disease progression and pathological changes, therefore it is indispensable for the development of novel therapeutics, vaccines, and diagnostic assays for nocardiosis. To date, well-established mice models have been developed for pulmonary nocardiosis, CNS <italic>Nocardia</italic> infection, <italic>Nocardia</italic> mycetoma, and <italic>Nocardia</italic> keratitis (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>). As early as the 1960s, infection models of <italic>N. asteroides</italic> and <italic>N. brasiliensis</italic> were established in Swiss white mice (<xref ref-type="bibr" rid="B19">Folb et&#xa0;al., 1976</xref>; <xref ref-type="bibr" rid="B21">Gonz&#xe1;lez-Ochoa, 1969</xref>). Subsequently, Salinas-Carmona et&#xa0;al. developed a BALB/c mice model of <italic>N. brasiliensis</italic>&#x2013;induced mycetoma (<xref ref-type="bibr" rid="B54">Salinas-Carmona et&#xa0;al., 1999</xref>). Beaman et&#xa0;al. established a pulmonary nocardiosis model in Swiss Webster mice via intranasal inoculation (<xref ref-type="bibr" rid="B7">Beaman et&#xa0;al., 1978</xref>), which was further optimized by Mifuji Lira et&#xa0;al., who developed a granulomatous pulmonary nocardiosis model caused by <italic>N. brasiliensis</italic> in BALB/c mice (<xref ref-type="bibr" rid="B45">Mifuji Lira et&#xa0;al., 2016</xref>). Our laboratory established a BALB/c mice model of CNS <italic>Nocardia</italic> infection caused by <italic>N. farcinica</italic> and demonstrated that disease outcomes vary depending on the route of inoculation (<xref ref-type="bibr" rid="B58">Shen et&#xa0;al., 2024a</xref>). Both intravenous and intraperitoneal routes were shown to induce CNS manifestations in mice (<xref ref-type="bibr" rid="B58">Shen et&#xa0;al., 2024a</xref>; <xref ref-type="bibr" rid="B31">Ji et&#xa0;al., 2022</xref>). In addition, Guo et&#xa0;al. established a <italic>Nocardia</italic> keratitis model in C57BL/6N mice (<xref ref-type="bibr" rid="B22">Guo et&#xa0;al., 2024</xref>). More recently, our laboratory further optimized the pulmonary infection model by developing an intratracheal aerosolization model in C57BL/6J mice, which closely recapitulates human infection via inhalation of <italic>Nocardia</italic>-containing aerosol particles (<xref ref-type="bibr" rid="B16">Du et&#xa0;al., 2025c</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Schematic diagram of mouse models of <italic>Nocardia</italic> infection.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1780562-g001.tif">
<alt-text content-type="machine-generated">Circular infographic illustrating seven experimental mouse models for Nocardia infection: intratracheal aerosolization, intranasal inoculation, actinomycetoma, intratracheal instillation, intravenous and intraperitoneal injection, and keratitis, each depicted with labeled diagrams of application methods surrounding a central image of Nocardia bacteria.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Other animal models</title>
<p>In addition to mice models, Sundararaj et&#xa0;al. established a guinea pig model of <italic>N. asteroides</italic> infection via intraperitoneal inoculation (<xref ref-type="bibr" rid="B63">Sundararaj and Agarwal, 1978</xref>). Mikami et&#xa0;al. developed a <italic>Nocardia</italic> infection model using the silkworm, which allows for quantitative evaluation of <italic>Nocardia</italic> pathogenicity as well as the therapeutic efficacy of antimicrobial agents against nocardiosis (<xref ref-type="bibr" rid="B46">Mikami et&#xa0;al., 2021</xref>). Furthermore, Bernardin Souibgui et&#xa0;al. established a nematode <italic>Caenorhabditis elegans</italic> model capable of detecting <italic>Nocardia</italic> strains involved in neurodegeneration, thereby markedly improving screening efficiency (<xref ref-type="bibr" rid="B8">Bernardin Souibgui et&#xa0;al., 2017</xref>).</p>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>Mechanism of <italic>Nocardia-</italic>host interactions</title>
<sec id="s4_1">
<label>4.1</label>
<title>Virulence factors of <italic>Nocardia</italic></title>
<p>At present, studies on the mechanisms of <italic>Nocardia</italic> host interactions remain limited (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>), and the pathogenic mechanisms of <italic>Nocardia</italic> are still not fully understood. Research on <italic>Nocardia</italic> virulence factors has primarily focused on type strains of <italic>N. farcinica</italic>, <italic>N. brasiliensis</italic>, and <italic>N. cyriacigeorgica</italic>, with virulence factors mainly comprising virulence proteins identified through animal and cell experiments, as well as putative virulence factors predicted by genomic analyses (<xref ref-type="bibr" rid="B30">Ishikawa et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B83">Zoropogui et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B71">Vera-Cabrera et&#xa0;al., 2013</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Mechanism of <italic>Nocardia</italic>-host interactions.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1780562-g002.tif">
<alt-text content-type="machine-generated">Illustration depicts the infection mechanism of Nocardia bacteria, including epithelial invasion via Mce proteins, interactions with microglial and macrophage cells, immune modulator release, phagosome survival, and neutrophil recruitment leading to tissue damage.</alt-text>
</graphic></fig>
<p>Invasion of host cells is a key pathogenic mechanism of intracellular pathogens. Mammalian cell entry (Mce) proteins are among the virulence factors of <italic>Mycobacterium tuberculosis</italic> and play important roles in host pathogen interactions (<xref ref-type="bibr" rid="B2">Arruda et&#xa0;al., 1993</xref>). Previous genomic sequencing studies have shown that <italic>N. farcinica</italic>, <italic>N. brasiliensis</italic>, and <italic>N. cyriacigeorgica</italic> each harbor six <italic>mce</italic> operons (<italic>mce1</italic> - <italic>mce6</italic>), which are involved in adhesion to and invasion of host cells (<xref ref-type="bibr" rid="B30">Ishikawa et&#xa0;al., 2004</xref>). In the absence of Mce proteins, <italic>N. brasiliensis</italic> completely loses its virulence in BALB/c mice (<xref ref-type="bibr" rid="B20">Gonzalez-Carrillo et&#xa0;al., 2016</xref>). Our previous studies demonstrated that the Mce1C and Mce1D proteins promote invasion of <italic>N. farcinica</italic> into HeLa cells and suppress host innate immune responses by modulating the NF-&#x3ba;B and MAPK signaling pathways (<xref ref-type="bibr" rid="B34">Ji et&#xa0;al., 2020b</xref>). In addition, <italic>mce1E</italic> may facilitate interactions between <italic>N. farcinica</italic> and mammalian cells (<xref ref-type="bibr" rid="B32">Ji et&#xa0;al., 2017</xref>).</p>
<p>Following host cell invasion, intracellular survival is a critical determinant of <italic>Nocardia</italic> pathogenicity. To counteract the oxidative burst generated by phagocytes, <italic>Nocardia</italic> expresses multiple antioxidant enzymes. Catalases degrade hydrogen peroxide, while superoxide dismutases degrade phagocyte-derived peroxides and singlet oxygen, thereby enabling Nocardia to persist and remain viable within phagocytic cells. Ishikawa et&#xa0;al. identified four catalases (<italic>KatA</italic>, <italic>KatB</italic>, <italic>KatC</italic>, and <italic>KatG</italic>), two superoxide dismutases (<italic>SodC</italic> and <italic>SodF</italic>), and one alkyl hydroperoxide reductase (AhpD) in <italic>N. farcinica</italic> IFM10152 (<xref ref-type="bibr" rid="B30">Ishikawa et&#xa0;al., 2004</xref>). Similarly, a catalase (<italic>KatN</italic>) and a superoxide dismutase (<italic>SodS</italic>) have been identified in <italic>N. brasiliensis</italic> (<xref ref-type="bibr" rid="B71">Vera-Cabrera et&#xa0;al., 2013</xref>). Collectively, these antioxidant enzymes are likely to play crucial roles in protecting <italic>Nocardia</italic> against phagocyte-derived reactive oxygen species and facilitating intracellular persistence.</p>
<p>Phospholipase C proteins may represent important virulence factors in <italic>N. brasiliensis</italic> but have not been identified in <italic>N. farcinica</italic> or <italic>N. cyriacigeorgica</italic> (<xref ref-type="bibr" rid="B79">Xia et&#xa0;al., 2017</xref>). Vera-Cabrera et&#xa0;al. identified four phospholipase C proteins (O3I_010265, O3I_012930, O3I_019520, and O3I_025065) in <italic>N. brasiliensis</italic> HUJEG-1 (<xref ref-type="bibr" rid="B71">Vera-Cabrera et&#xa0;al., 2013</xref>), suggesting a potential role for these enzymes in the pathogenesis of <italic>N. brasiliensis</italic>. However, direct evidence for their involvement in lung tissue damage or pulmonary dysfunction in nocardiosis remains lacking, as such effects have thus far been demonstrated only in other microorganisms (<xref ref-type="bibr" rid="B74">Wargo et&#xa0;al., 2011</xref>). Further functional studies are therefore required to clarify the contribution of phospholipase C to <italic>Nocardia</italic> virulence.</p>
<p>Hemolysins are recognized as important virulence proteins in bacterial pathogenesis (<xref ref-type="bibr" rid="B1">Adhikari et&#xa0;al., 2012</xref>). The genome of <italic>N. brasiliensis</italic> HUJEG-1 encodes four hemolysins (O3I_012605, O3I_013705, O3I_036360, and O3I_037730) (<xref ref-type="bibr" rid="B71">Vera-Cabrera et&#xa0;al., 2013</xref>), suggesting a potential contribution of these proteins to the pathogenicity of <italic>N. brasiliensis</italic>. Among them, O3I_012605 appears to be specific to <italic>N. brasiliensis</italic>, whereas homologs of the other three hemolysins can be identified in other <italic>Nocardia</italic> species. However, the precise roles of these hemolysins in <italic>Nocardia</italic> infection and host tissue damage remain unclear and require further experimental validation.</p>
<p>Siderophores are chelating compounds produced by pathogenic microorganisms to facilitate survival in iron-limited host environments. <italic>Nocardia</italic> species are capable of producing multiple siderophores, which have been implicated in host tissue damage during infection (<xref ref-type="bibr" rid="B29">Ikeda et&#xa0;al., 2005</xref>). Siderophore biosynthesis is associated with the <italic>nbtA</italic>-<italic>H</italic> gene cluster, which encodes two polyketide synthases (NbtB and NbtC), three nonribosomal peptide synthetases (NbtD, NbtE, and NbtF), two lysine-modifying proteins (NbtG and NbtH), and a receptor protein (NbtI) (<xref ref-type="bibr" rid="B50">Quadri et&#xa0;al., 1998</xref>). Functional studies have suggested a role for <italic>nbtB</italic> and <italic>nbtS</italic> in <italic>N. farcinica</italic> virulence, as deletion of these genes was associated with significantly improved survival in infected mice (<xref ref-type="bibr" rid="B31">Ji et&#xa0;al., 2022</xref>). Notably, the salicylate synthase NbtS has emerged as a pivotal mediator in the molecular pathogenesis of CNS nocardiosis. Beyond its metabolic role, <italic>nbtS</italic> has been implicated in triggering potent neuroinflammatory responses both <italic>in vitro</italic> and <italic>in vivo</italic>. Mechanistic investigations further demonstrated that NbtS directly interacts with microglial cells (BV2 and human microglial clone 3) and serves as a key ligand that activates the toll-like receptor 4 (TLR4)&#x2013;dependent MyD88&#x2013;IRAK4&#x2013;IRAK1 signaling cascade. This engagement subsequently triggers the MAPK and nuclear factor kappa B (NF-&#x3ba;B) pathways, resulting in significantly enhanced pro-inflammatory responses, as evidenced by the massive production of tumor necrosis factor alpha (TNF-&#x3b1;) and interleukin-1&#x3b2; (IL-1&#x3b2;). Such excessive cytokine release is a critical driver of the neural tissue damage and high mortality associated with brain <italic>Nocardia</italic> infections. Collectively, these findings suggest that siderophore-associated proteins, particularly NbtS, are essential for <italic>Nocardia</italic>-induced neuroinflammation, though the full landscape of their role in systemic pathogenicity warrants further exploration (<xref ref-type="bibr" rid="B59">Shen et&#xa0;al., 2024b</xref>; <xref ref-type="bibr" rid="B57">Shen et&#xa0;al., 2025</xref>).</p>
<p>Genome sequencing analyses of <italic>Nocardia</italic> have indicated that its repertoire of putative virulence proteins includes invasins, nitrate reductases, proline&#x2013;glutamate/proline&#x2013;glutamate (PE/PPE) proteins, lipases, HBHA, NFA34810, and NFA52080. Some of these factors have been implicated in host infection, and previous studies have provided experimental evidence supporting the involvement of HBHA and NFA34810 in <italic>Nocardia</italic> virulence (<xref ref-type="bibr" rid="B33">Ji et&#xa0;al., 2020a</xref>; <xref ref-type="bibr" rid="B4">Beaman, 1996</xref>). However, the functional roles of many other predicted virulence-associated proteins remain largely unexplored and require further experimental validation.</p>
<p>Beyond protein-based factors, cell wall components play a regulatory role. Trevino-Villarreal et&#xa0;al. demonstrated that <italic>N. brasiliensis</italic> cell wall lipids modulate the responses of macrophages and dendritic cells, creating an environment that favors the development of experimental actinomycetoma (<xref ref-type="bibr" rid="B68">Trevino-Villarreal et&#xa0;al., 2012</xref>).</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>Host bactericidal mechanisms</title>
<p>Following <italic>Nocardia</italic> infection, the host rapidly initiates innate immune responses to eliminate both intracellular and extracellular pathogens. The essentiality of these defensive components is best illustrated by the heightened susceptibility of patients with specific immunodeficiencies, which allows for a systematic dissection of the host&#x2019;s protective network. However, the immunological mechanisms underlying host defense against <italic>Nocardia</italic> remain incompletely understood. Clinical observations of fulminant infections in neutropenic patients or those with impaired neutrophil function further confirm that these cells are the primary executioners of bacterial clearance (<xref ref-type="bibr" rid="B47">Moore et&#xa0;al., 2000</xref>). Accumulating evidence indicates that neutrophils play a central role in host survival and the resolution of pulmonary nocardiosis. Shortly after intranasal inoculation with <italic>N. cyriacigeorgica</italic> GUH-2, bacteria invade the pulmonary epithelium and trigger a robust inflammatory response characterized by extensive neutrophil recruitment, ultimately leading to acute necrotizing pneumonia (<xref ref-type="bibr" rid="B4">Beaman, 1996</xref>). In the absence of neutrophils, <italic>Nocardia</italic> proliferates uncontrollably, potentially accompanied by enhanced invasion of pulmonary epithelial cells, resulting in increased cellular injury and aggravated histopathological damage (<xref ref-type="bibr" rid="B47">Moore et&#xa0;al., 2000</xref>). Consistently, blockade of CXCR2 signaling prior to infection significantly increases mortality in mice, further underscoring the indispensable role of neutrophil-mediated defense against <italic>Nocardia</italic> infection (<xref ref-type="bibr" rid="B47">Moore et&#xa0;al., 2000</xref>).</p>
<p>Beyond innate immune cells, &#x3b3;&#x3b4;T cells have emerged as key immunoregulatory lymphocytes involved in immune surveillance and maintenance of immune homeostasis (<xref ref-type="bibr" rid="B27">Hayday and Tigelaar, 2003</xref>). Increasing evidence suggests that &#x3b3;&#x3b4;T cells promote protective immunity largely through the induction and regulation of neutrophil responses (<xref ref-type="bibr" rid="B23">Hamada et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B56">Schulz et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B60">Shibata et&#xa0;al., 2007</xref>). In particular, interleukin-17 (IL-17) produced by &#x3b3;&#x3b4;T cells has been shown to induce CXC chemokines, granulocyte colony-stimulating factor (G-CSF), and adhesion molecules, thereby enhancing neutrophil recruitment, activation, and antimicrobial function against both intracellular and extracellular bacterial pathogens (<xref ref-type="bibr" rid="B60">Shibata et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B36">Kolls and Lind&#xe9;n, 2004</xref>; <xref ref-type="bibr" rid="B39">Lind&#xe9;n et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B10">Caccamo et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B69">Umemura et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B42">Markel et&#xa0;al., 2010</xref>). Notably, &#x3b3;&#x3b4; T cell&#x2013;deficient mice infected with a nonlethal dose of <italic>N. cyriacigeorgica</italic> GUH-2 develop severe disease and succumb within two weeks (<xref ref-type="bibr" rid="B35">King et&#xa0;al., 1999</xref>). Furthermore, Tam et&#xa0;al. demonstrated that &#x3b3;&#x3b4;T cells and IL-17 are essential for effective neutrophil infiltration and bacterial killing following <italic>N. cyriacigeorgica</italic> GUH-2 infection in mice (<xref ref-type="bibr" rid="B64">Tam et&#xa0;al., 2012</xref>). This experimental evidence mirrors the high prevalence of nocardiosis in patients with low CD4+ T-lymphocyte counts, such as HIV-infected individuals, highlighting that T cell orchestrated cytokine signaling is the mandatory &#x201c;command center&#x201d; for initiating an effective innate response (<xref ref-type="bibr" rid="B18">Filice, 2005</xref>). Collectively, these findings highlight a critical &#x3b3;&#x3b4;T cell&#x2013;IL-17&#x2013;neutrophil axis in host defense against <italic>Nocardia</italic>, although the precise regulatory mechanisms governing this immune network remain to be further elucidated.</p>
<p>While host bactericidal mechanisms aim to eliminate the pathogen, certain inflammatory mediators can paradoxically contribute to disease progression. Recent evidence suggests that nitric oxide (NO) may promote <italic>Nocardia</italic> pathogenesis rather than clearance. Salinas-Carmona et&#xa0;al. found that blocking inducible nitric oxide synthase (iNOS) protects mice from <italic>N. brasiliensis</italic>-induced actinomycetoma (<xref ref-type="bibr" rid="B53">Salinas-Carmona et&#xa0;al., 2020</xref>). Similarly, Yao et&#xa0;al. demonstrated that NO contributes to the pathogenesis of <italic>N. farcinica</italic> infection in both mouse models and alveolar MH-S macrophages (<xref ref-type="bibr" rid="B80">Yao et&#xa0;al., 2025</xref>).</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>Mechanisms of intracellular survival of <italic>Nocardia</italic></title>
<p>Beyond adhesion to and invasion of host cells, the capacity of <italic>Nocardia</italic> to persist within host tissues and cells constitutes a critical pathogenic mechanism. Meester et&#xa0;al. reported that <italic>Nocardia</italic> infection induces macrophages and dendritic cells to differentiate into foam cells, thereby impairing their microbicidal functions, although the underlying mechanisms remain poorly defined (<xref ref-type="bibr" rid="B44">Meester et&#xa0;al., 2014</xref>). Beaman et&#xa0;al. further demonstrated that <italic>Nocardia</italic> can survive for prolonged periods within macrophages without being eliminated by phagocytic killing. This intracellular persistence is thought to result from multiple immune evasion strategies, including inhibition of phagosome&#x2013;lysosome fusion, suppression of proteasomal activity, interference with phagosomal acidification, alteration of lysosomal enzyme activity, and resistance to oxidative killing. The critical importance of the host&#x2019;s oxidative burst is underscored by the high clinical vulnerability of patients with chronic granulomatous disease (CGD), whose inability to generate reactive oxygen species (ROS) provides <italic>Nocardia</italic> a permissive environment for uncontrolled replication (<xref ref-type="bibr" rid="B13">Dorman et&#xa0;al., 2002</xref>). Collectively, these mechanisms compromise the bactericidal capacity of phagocytic cells and enable long-term intracellular survival of <italic>Nocardia</italic> (<xref ref-type="bibr" rid="B5">Beaman and Beaman, 1994</xref>; <xref ref-type="bibr" rid="B3">Barry and Beaman, 2007</xref>). These mechanisms are highly reminiscent of the intracellular survival strategies of <italic>Mycobacterium</italic>, which also manipulate the phagosomal environment to avoid lysosomal degradation. Furthermore, <italic>Nocardia</italic> can manipulate the host immune landscape to ensure persistence (<xref ref-type="bibr" rid="B5">Beaman and Beaman, 1994</xref>). Rosas-Taraco et&#xa0;al. reported that <italic>N. brasiliensis</italic> induces an immunosuppressive microenvironment characterized by specific cytokine profiles that that benefits its survival during the chronic stage of infection (<xref ref-type="bibr" rid="B51">Rosas-Taraco et&#xa0;al., 2012</xref>). Additionally, the pathogen directly impacts host cell viability; Navarro-Dur&#xe1;n et&#xa0;al. demonstrated that <italic>N. brasiliensis</italic> infection induces macrophage cell death, a process that likely facilitates tissue damage and further dissemination of the bacteria (<xref ref-type="bibr" rid="B48">Navarro-Dur&#xe1;n et&#xa0;al., 2022</xref>).</p>
</sec>
</sec>
<sec id="s5">
<label>5</label>
<title>Current challenges and future perspectives</title>
<p>Despite significant progress in identifying the molecular determinants of <italic>Nocardia</italic> pathogenicity, several critical gaps remain. First, much of our current understanding is derived from a limited number of laboratory type strains, such as <italic>N. farcinica</italic> IFM 10152 and <italic>N. cyriacigeorgica</italic> GUH-2. Given the high genomic plasticity and clinical diversity of the <italic>Nocardia</italic> genus, it is unclear whether these mechanisms are universally conserved across emerging pathogenic species and highly resistant clinical isolates. Future research must prioritize the comparative analysis of clinical strains to capture the full spectrum of virulence.</p>
<p>Second, while genomic and bioinformatic tools have predicted a vast array of potential virulence factors, only a small fraction has been functionally validated. The integration of omics technologies, including transcriptomics, proteomics, and metabolomics, during <italic>in vivo</italic> infection is essential toward a dynamic understanding of host-pathogen interactions.</p>
</sec>
<sec id="s6" sec-type="conclusions">
<label>6</label>
<title>Conclusion</title>
<p>In conclusion, multiple virulence determinants, including Mce proteins, antioxidant enzymes, phospholipase C, hemolysins, and siderophore-associated proteins, collectively contribute to <italic>Nocardia</italic> host cell invasion, immune evasion, and tissue persistence. These virulence determinants not only facilitate tissue colonization but also enable evasion of host immune responses, particularly by interfering with phagocyte microbicidal functions, phagosome&#x2013;lysosome fusion, proteasomal activity, and oxidative killing. Host defense against <italic>Nocardia</italic> relies heavily on innate immune mechanisms, with neutrophils and CXC chemokines forming a critical first line of defense. &#x3b3;&#x3b4;T cells and IL-17 further orchestrate protective neutrophil responses, highlighting a key &#x3b3;&#x3b4;T cell&#x2013;IL-17&#x2013;neutrophil axis in controlling infection. Despite these insights, the precise molecular mechanisms underlying <italic>Nocardia</italic> intracellular survival, immune evasion, and host&#x2013;pathogen interactions remain incompletely understood. Future studies integrating genomics, functional assays, and animal models are essential to elucidate these pathways, which may inform the development of targeted therapeutics, vaccines, and diagnostic strategies for nocardiosis.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>BD: Formal analysis, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. ZS: Conceptualization, Visualization, Writing &#x2013; review &amp; editing. MY: Conceptualization, Writing &#x2013; review &amp; editing. YD: Conceptualization, Writing &#x2013; review &amp; editing. SX: Writing &#x2013; review &amp; editing. XQ: Writing &#x2013; review &amp; editing. ZL: Conceptualization, Formal analysis, Funding acquisition, Supervision, Writing &#x2013; review &amp; editing.</p></sec>
<ack>
<title>Acknowledgments</title>
<p>We are grateful to all researchers who have made significant contributions to <italic>Nocardia</italic> research.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Adhikari</surname> <given-names>R. P.</given-names></name>
<name><surname>Karauzum</surname> <given-names>H.</given-names></name>
<name><surname>Sarwar</surname> <given-names>J.</given-names></name>
<name><surname>Abaandou</surname> <given-names>L.</given-names></name>
<name><surname>Mahmoudieh</surname> <given-names>M.</given-names></name>
<name><surname>Boroun</surname> <given-names>A. R.</given-names></name>
<etal/>
</person-group>. (<year>2012</year>). 
<article-title>Novel structurally designed vaccine for S. aureus &#x3b1;-hemolysin: protection against bacteremia and pneumonia</article-title>. <source>PloS One</source> <volume>7</volume>, <fpage>e38567</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0038567</pub-id>, PMID: <pub-id pub-id-type="pmid">22701668</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Arruda</surname> <given-names>S.</given-names></name>
<name><surname>Bomfim</surname> <given-names>G.</given-names></name>
<name><surname>Knights</surname> <given-names>R.</given-names></name>
<name><surname>Huima-Byron</surname> <given-names>T.</given-names></name>
<name><surname>Riley</surname> <given-names>L. W.</given-names></name>
</person-group> (<year>1993</year>). 
<article-title>Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells</article-title>. <source>Science</source> <volume>261</volume>, <fpage>1454</fpage>&#x2013;<lpage>1457</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.8367727</pub-id>, PMID: <pub-id pub-id-type="pmid">8367727</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Barry</surname> <given-names>D. P.</given-names></name>
<name><surname>Beaman</surname> <given-names>B. L.</given-names></name>
</person-group> (<year>2007</year>). 
<article-title>Nocardia asteroides strain GUH-2 induces proteasome inhibition and apoptotic death of cultured cells</article-title>. <source>Res. Microbiol.</source> <volume>158</volume>, <fpage>86</fpage>&#x2013;<lpage>96</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.resmic.2006.11.001</pub-id>, PMID: <pub-id pub-id-type="pmid">17258894</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Beaman</surname> <given-names>B. L.</given-names></name>
</person-group> (<year>1996</year>). 
<article-title>Differential binding of Nocardia asteroides in the murine lung and brain suggests multiple ligands on the nocardial surface</article-title>. <source>Infect. Immun.</source> <volume>64</volume>, <fpage>4859</fpage>&#x2013;<lpage>4862</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.64.11.4859-4862.1996</pub-id>, PMID: <pub-id pub-id-type="pmid">8890253</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Beaman</surname> <given-names>B. L.</given-names></name>
<name><surname>Beaman</surname> <given-names>L.</given-names></name>
</person-group> (<year>1994</year>). 
<article-title>Nocardia species: host-parasite relationships</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>7</volume>, <fpage>213</fpage>&#x2013;<lpage>264</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.7.2.213</pub-id>, PMID: <pub-id pub-id-type="pmid">8055469</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Beaman</surname> <given-names>B. L.</given-names></name>
<name><surname>Burnside</surname> <given-names>J.</given-names></name>
<name><surname>Edwards</surname> <given-names>B.</given-names></name>
<name><surname>Causey</surname> <given-names>W.</given-names></name>
</person-group> (<year>1976</year>). 
<article-title>Nocardial infections in the United States 1972-1974</article-title>. <source>J. Infect. Dis.</source> <volume>134</volume>, <fpage>286</fpage>&#x2013;<lpage>289</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/134.3.286</pub-id>, PMID: <pub-id pub-id-type="pmid">789786</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Beaman</surname> <given-names>B. L.</given-names></name>
<name><surname>Goldstein</surname> <given-names>E.</given-names></name>
<name><surname>Gershwin</surname> <given-names>M. E.</given-names></name>
<name><surname>Maslan</surname> <given-names>S.</given-names></name>
<name><surname>Lippert</surname> <given-names>W.</given-names></name>
</person-group> (<year>1978</year>). 
<article-title>Lung response to congenitally athymic (nude), heterozygous, and Swiss Webster mice to aerogenic and intranasal infection by Nocardia asteroides</article-title>. <source>Infect. Immun.</source> <volume>22</volume>, <fpage>867</fpage>&#x2013;<lpage>877</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.22.3.867-877.1978</pub-id>, PMID: <pub-id pub-id-type="pmid">365772</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bernardin Souibgui</surname> <given-names>C.</given-names></name>
<name><surname>Zoropogui</surname> <given-names>A.</given-names></name>
<name><surname>Voisin</surname> <given-names>J.</given-names></name>
<name><surname>Ribun</surname> <given-names>S.</given-names></name>
<name><surname>Vasselon</surname> <given-names>V.</given-names></name>
<name><surname>Pujic</surname> <given-names>P.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Virulence test using nematodes to prescreen Nocardia species capable of inducing neurodegeneration and behavioral disorders</article-title>. <source>PeerJ</source> <volume>5</volume>, <fpage>e3823</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7717/peerj.3823</pub-id>, PMID: <pub-id pub-id-type="pmid">29038748</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brown-Elliott</surname> <given-names>B. A.</given-names></name>
<name><surname>Brown</surname> <given-names>J. M.</given-names></name>
<name><surname>Conville</surname> <given-names>P. S.</given-names></name>
<name><surname>Wallace</surname> <given-names>R. J.</given-names> <suffix>Jr.</suffix></name>
</person-group> (<year>2006</year>). 
<article-title>Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>19</volume>, <fpage>259</fpage>&#x2013;<lpage>282</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.19.2.259-282.2006</pub-id>, PMID: <pub-id pub-id-type="pmid">16614249</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Caccamo</surname> <given-names>N.</given-names></name>
<name><surname>La Mendola</surname> <given-names>C.</given-names></name>
<name><surname>Orlando</surname> <given-names>V.</given-names></name>
<name><surname>Meraviglia</surname> <given-names>S.</given-names></name>
<name><surname>Todaro</surname> <given-names>M.</given-names></name>
<name><surname>Stassi</surname> <given-names>G.</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). 
<article-title>Differentiation, phenotype, and function of interleukin-17-producing human V&#x3b3;9V&#x3b4;2 T cells</article-title>. <source>Blood</source> <volume>118</volume>, <fpage>129</fpage>&#x2013;<lpage>138</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2011-01-331298</pub-id>, PMID: <pub-id pub-id-type="pmid">21505189</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>W.</given-names></name>
<name><surname>Liu</surname> <given-names>Y.</given-names></name>
<name><surname>Zhang</surname> <given-names>L.</given-names></name>
<name><surname>Gu</surname> <given-names>X.</given-names></name>
<name><surname>Liu</surname> <given-names>G.</given-names></name>
<name><surname>Shahid</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Nocardia cyriacigeogica from Bovine Mastitis Induced <italic>In vitro</italic> Apoptosis of Bovine Mammary Epithelial Cells via Activation of Mitochondrial-Caspase Pathway</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2017.00194</pub-id>, PMID: <pub-id pub-id-type="pmid">28573110</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Coussement</surname> <given-names>J.</given-names></name>
<name><surname>Lebeaux</surname> <given-names>D.</given-names></name>
<name><surname>van Delden</surname> <given-names>C.</given-names></name>
<name><surname>Guillot</surname> <given-names>H.</given-names></name>
<name><surname>Freund</surname> <given-names>R.</given-names></name>
<name><surname>Marbus</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2016</year>). 
<article-title>Nocardia infection in solid organ transplant recipients: A multicenter european case-control study</article-title>. <source>Clin. Infect. Dis.</source> <volume>63</volume>, <fpage>338</fpage>&#x2013;<lpage>345</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/ciw241</pub-id>, PMID: <pub-id pub-id-type="pmid">27090987</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dorman</surname> <given-names>S. E.</given-names></name>
<name><surname>Guide</surname> <given-names>S. V.</given-names></name>
<name><surname>Conville</surname> <given-names>P. S.</given-names></name>
<name><surname>DeCarlo</surname> <given-names>E. S.</given-names></name>
<name><surname>Malech</surname> <given-names>H. L.</given-names></name>
<name><surname>Gallin</surname> <given-names>J. I.</given-names></name>
<etal/>
</person-group>. (<year>2002</year>). 
<article-title>Nocardia infection in chronic granulomatous disease</article-title>. <source>Clin. Infect. Dis.</source> <volume>35</volume>, <fpage>390</fpage>&#x2013;<lpage>394</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/341416</pub-id>, PMID: <pub-id pub-id-type="pmid">12145721</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Du</surname> <given-names>B.</given-names></name>
<name><surname>Song</surname> <given-names>Z.</given-names></name>
<name><surname>Jia</surname> <given-names>H.</given-names></name>
<name><surname>Liu</surname> <given-names>Z.</given-names></name>
<name><surname>Yuan</surname> <given-names>M.</given-names></name>
<name><surname>Li</surname> <given-names>Z.</given-names></name>
</person-group> (<year>2025</year>a). 
<article-title>Clinical characteristics of global HIV combined with Nocardia infection cases 1985-2024</article-title>. <source>Dis. Surveillance</source> <volume>40</volume>, <fpage>1065</fpage>&#x2013;<lpage>1071</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3784/jbjc.202410220598</pub-id>, PMID: <pub-id pub-id-type="pmid">14686848</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Du</surname> <given-names>B.</given-names></name>
<name><surname>Song</surname> <given-names>Z.</given-names></name>
<name><surname>Ren</surname> <given-names>Z.</given-names></name>
<name><surname>Tang</surname> <given-names>D.</given-names></name>
<name><surname>Shen</surname> <given-names>J.</given-names></name>
<name><surname>Yao</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>b). 
<article-title>The global epidemiology, risk factors, and mortality prediction of nocardiosis: an easily missed opportunistic infection</article-title>. <source>Sci. Rep.</source> <volume>15</volume>, <fpage>42090</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-025-26244-1</pub-id>, PMID: <pub-id pub-id-type="pmid">41298615</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Du</surname> <given-names>B.</given-names></name>
<name><surname>Song</surname> <given-names>Z.</given-names></name>
<name><surname>Shen</surname> <given-names>J.</given-names></name>
<name><surname>Yao</surname> <given-names>J.</given-names></name>
<name><surname>Xu</surname> <given-names>S.</given-names></name>
<name><surname>Qiu</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>c). 
<article-title>Intratracheal aerosolization of nocardia farcinica in mice optimizes bacterial distribution and enhances pathogenicity compared to intranasal inoculation and intratracheal instillation</article-title>. <source>Biomolecules</source> <volume>15</volume>, <elocation-id>950</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biom15070950</pub-id>, PMID: <pub-id pub-id-type="pmid">40723822</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Exmelin</surname> <given-names>L.</given-names></name>
<name><surname>Malbruny</surname> <given-names>B.</given-names></name>
<name><surname>Vergnaud</surname> <given-names>M.</given-names></name>
<name><surname>Prosvost</surname> <given-names>F.</given-names></name>
<name><surname>Boiron</surname> <given-names>P.</given-names></name>
<name><surname>Morel</surname> <given-names>C.</given-names></name>
</person-group> (<year>1996</year>). 
<article-title>Molecular study of nosocomial nocardiosis outbreak involving heart transplant recipients</article-title>. <source>J. Clin. Microbiol.</source> <volume>34</volume>, <fpage>1014</fpage>&#x2013;<lpage>1016</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jcm.34.4.1014-1016.1996</pub-id>, PMID: <pub-id pub-id-type="pmid">8815073</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Filice</surname> <given-names>G. A.</given-names></name>
</person-group> (<year>2005</year>). 
<article-title>Nocardiosis in persons with human immunodeficiency virus infection, transplant recipients, and large, geographically defined populations</article-title>. <source>J. Lab. Clin. Med.</source> <volume>145</volume>, <fpage>156</fpage>&#x2013;<lpage>162</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lab.2005.01.002</pub-id>, PMID: <pub-id pub-id-type="pmid">15871308</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Folb</surname> <given-names>P. I.</given-names></name>
<name><surname>Jaffe</surname> <given-names>R.</given-names></name>
<name><surname>Altmann</surname> <given-names>G.</given-names></name>
</person-group> (<year>1976</year>). 
<article-title>Nocardia asteroides and Nocardia brasiliensis infections in mice</article-title>. <source>Infect. Immun.</source> <volume>13</volume>, <fpage>1490</fpage>&#x2013;<lpage>1496</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.13.5.1490-1496.1976</pub-id>, PMID: <pub-id pub-id-type="pmid">773837</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gonzalez-Carrillo</surname> <given-names>C.</given-names></name>
<name><surname>Millan-Sauceda</surname> <given-names>C.</given-names></name>
<name><surname>Lozano-Garza</surname> <given-names>H. G.</given-names></name>
<name><surname>Ortiz-Lopez</surname> <given-names>R.</given-names></name>
<name><surname>Elizondo-Gonzalez</surname> <given-names>R.</given-names></name>
<name><surname>Welsh</surname> <given-names>O.</given-names></name>
<etal/>
</person-group>. (<year>2016</year>). 
<article-title>Genomic Changes Associated with the Loss of Nocardia brasiliensis Virulence in Mice after 200 <italic>In Vitro</italic> Passages</article-title>. <source>Infect. Immun.</source> <volume>84</volume>, <fpage>2595</fpage>&#x2013;<lpage>2606</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00329-16</pub-id>, PMID: <pub-id pub-id-type="pmid">27354446</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gonz&#xe1;lez-Ochoa</surname> <given-names>A.</given-names></name>
</person-group> (<year>1969</year>). 
<article-title>Produccion experimental del micetoma por Nocardia brasiliensis en el rat&#xf3;n [Experimental production of mycetoma by Nocardia Braziliensis in the mouse</article-title>. <source>Gac Med. Mex.</source> <volume>99</volume>, <fpage>773</fpage>&#x2013;<lpage>781</lpage>.
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Guo</surname> <given-names>X.</given-names></name>
<name><surname>Zhang</surname> <given-names>Z.</given-names></name>
<name><surname>Chen</surname> <given-names>Q.</given-names></name>
<name><surname>Wang</surname> <given-names>L.</given-names></name>
<name><surname>Xu</surname> <given-names>X.</given-names></name>
<name><surname>Wei</surname> <given-names>Z.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Whole genome sequencing highlights the pathogenic profile in nocardia keratitis</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>65</volume>, <elocation-id>26</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1167/iovs.65.3.26</pub-id>, PMID: <pub-id pub-id-type="pmid">38502137</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hamada</surname> <given-names>S.</given-names></name>
<name><surname>Umemura</surname> <given-names>M.</given-names></name>
<name><surname>Shiono</surname> <given-names>T.</given-names></name>
<name><surname>Tanaka</surname> <given-names>K.</given-names></name>
<name><surname>Yahagi</surname> <given-names>A.</given-names></name>
<name><surname>Begum</surname> <given-names>M. D.</given-names></name>
<etal/>
</person-group>. (<year>2008</year>). 
<article-title>IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver</article-title>. <source>J. Immunol.</source> <volume>181</volume>, <fpage>3456</fpage>&#x2013;<lpage>3463</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.181.5.3456</pub-id>, PMID: <pub-id pub-id-type="pmid">18714018</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hamdi</surname> <given-names>A. M.</given-names></name>
<name><surname>Fida</surname> <given-names>M.</given-names></name>
<name><surname>Deml</surname> <given-names>S. M.</given-names></name>
<name><surname>Abu Saleh</surname> <given-names>O. M.</given-names></name>
<name><surname>Wengenack</surname> <given-names>N. L.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Retrospective analysis of antimicrobial susceptibility profiles of nocardia species from a tertiary hospital and reference laboratory 2011 to 2017</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>64</volume>, <fpage>e01868</fpage>&#x2013;<lpage>e01819</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.01868-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31818815</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Harpaz</surname> <given-names>R.</given-names></name>
<name><surname>Dahl</surname> <given-names>R. M.</given-names></name>
<name><surname>Dooling</surname> <given-names>K. L.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Prevalence of immunosuppression among US adult</article-title>. <source>JAMA</source> <volume>316</volume>, <fpage>2547</fpage>&#x2013;<lpage>2548</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jama.2016.16477</pub-id>, PMID: <pub-id pub-id-type="pmid">27792809</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hashemi-Shahraki</surname> <given-names>A.</given-names></name>
<name><surname>Heidarieh</surname> <given-names>P.</given-names></name>
<name><surname>Bostanabad</surname> <given-names>S. Z.</given-names></name>
<name><surname>Hashemzadeh</surname> <given-names>M.</given-names></name>
<name><surname>Feizabadi</surname> <given-names>M. M.</given-names></name>
<name><surname>Schraufnagel</surname> <given-names>D.</given-names></name>
<etal/>
</person-group>. (<year>2015</year>). 
<article-title>Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <elocation-id>17862</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep17862</pub-id>, PMID: <pub-id pub-id-type="pmid">26638771</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hayday</surname> <given-names>A.</given-names></name>
<name><surname>Tigelaar</surname> <given-names>R.</given-names></name>
</person-group> (<year>2003</year>). 
<article-title>Immunoregulation in the tissues by gammadelta T cells</article-title>. <source>Nat. Rev. Immunol.</source> <volume>3</volume>, <fpage>233</fpage>&#x2013;<lpage>242</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri1030</pub-id>, PMID: <pub-id pub-id-type="pmid">12658271</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hofflin</surname> <given-names>J. M.</given-names></name>
<name><surname>Potasman</surname> <given-names>I.</given-names></name>
<name><surname>Baldwin</surname> <given-names>J. C.</given-names></name>
<name><surname>Oyer</surname> <given-names>P. E.</given-names></name>
<name><surname>Stinson</surname> <given-names>E. B.</given-names></name>
<name><surname>Remington</surname> <given-names>J. S.</given-names></name>
</person-group> (<year>1987</year>). 
<article-title>Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids</article-title>. <source>Ann. Intern. Med.</source> <volume>106</volume>, <fpage>209</fpage>&#x2013;<lpage>216</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7326/0003-4819-106-2-209</pub-id>, PMID: <pub-id pub-id-type="pmid">3541723</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ikeda</surname> <given-names>Y.</given-names></name>
<name><surname>Nonaka</surname> <given-names>H.</given-names></name>
<name><surname>Furumai</surname> <given-names>T.</given-names></name>
<name><surname>Onaka</surname> <given-names>H.</given-names></name>
<name><surname>Igarashi</surname> <given-names>Y.</given-names></name>
</person-group> (<year>2005</year>). 
<article-title>Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674</article-title>. <source>J. Nat. Prod.</source> <volume>68</volume>, <fpage>1061</fpage>&#x2013;<lpage>1065</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/np050091j</pub-id>, PMID: <pub-id pub-id-type="pmid">16038549</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ishikawa</surname> <given-names>J.</given-names></name>
<name><surname>Yamashita</surname> <given-names>A.</given-names></name>
<name><surname>Mikami</surname> <given-names>Y.</given-names></name>
<name><surname>Hoshino</surname> <given-names>Y.</given-names></name>
<name><surname>Kurita</surname> <given-names>H.</given-names></name>
<name><surname>Hotta</surname> <given-names>K.</given-names></name>
<etal/>
</person-group>. (<year>2004</year>). 
<article-title>The complete genomic sequence of Nocardia farcinica IFM 10152</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>101</volume>, <fpage>14925</fpage>&#x2013;<lpage>14930</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0406410101</pub-id>, PMID: <pub-id pub-id-type="pmid">15466710</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ji</surname> <given-names>X.</given-names></name>
<name><surname>Han</surname> <given-names>L.</given-names></name>
<name><surname>Zhang</surname> <given-names>W.</given-names></name>
<name><surname>Sun</surname> <given-names>L.</given-names></name>
<name><surname>Xu</surname> <given-names>S.</given-names></name>
<name><surname>Qiu</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Molecular, cellular and neurological consequences of infection by the neglected human pathogen Nocardia</article-title>. <source>BMC Biol.</source> <volume>20</volume>, <fpage>251</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12915-022-01452-7</pub-id>, PMID: <pub-id pub-id-type="pmid">36352407</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ji</surname> <given-names>X.</given-names></name>
<name><surname>Tan</surname> <given-names>X.</given-names></name>
<name><surname>Hou</surname> <given-names>X.</given-names></name>
<name><surname>Si</surname> <given-names>C.</given-names></name>
<name><surname>Xu</surname> <given-names>S.</given-names></name>
<name><surname>Tang</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Cloning, Expression, Invasion, and Immunological Reactivity of a Mammalian Cell Entry Protein Encoded by the mce1 Operon of Nocardia farcinica</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2017.00281</pub-id>, PMID: <pub-id pub-id-type="pmid">28275374</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ji</surname> <given-names>X.</given-names></name>
<name><surname>Zhang</surname> <given-names>X.</given-names></name>
<name><surname>Sun</surname> <given-names>L.</given-names></name>
<name><surname>Hou</surname> <given-names>X.</given-names></name>
<name><surname>Song</surname> <given-names>H.</given-names></name>
<name><surname>Han</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>a). 
<article-title>The Heparin-Binding Hemagglutinin of Nocardia cyriacigeorgica GUH-2 Stimulates Inflammatory Cytokine Secretion Through Activation of Nuclear Factor &#x3ba;B and Mitogen-Activated Protein Kinase Pathways via TLR4</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.00003</pub-id>, PMID: <pub-id pub-id-type="pmid">32117792</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ji</surname> <given-names>X.</given-names></name>
<name><surname>Zhang</surname> <given-names>X.</given-names></name>
<name><surname>Sun</surname> <given-names>L.</given-names></name>
<name><surname>Hou</surname> <given-names>X.</given-names></name>
<name><surname>Song</surname> <given-names>J.</given-names></name>
<name><surname>Tan</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>b). 
<article-title>Mce1C and Mce1D facilitate N. farcinica invasion of host cells and suppress immune responses by inhibiting innate signaling pathways</article-title>. <source>Sci. Rep.</source> <volume>10</volume>, <fpage>14908</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-71860-8</pub-id>, PMID: <pub-id pub-id-type="pmid">32913259</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>King</surname> <given-names>D. P.</given-names></name>
<name><surname>Hyde</surname> <given-names>D. M.</given-names></name>
<name><surname>Jackson</surname> <given-names>K. A.</given-names></name>
<name><surname>Novosad</surname> <given-names>D. M.</given-names></name>
<name><surname>Ellis</surname> <given-names>T. N.</given-names></name>
<name><surname>Putney</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>1999</year>). 
<article-title>Cutting edge: protective response to pulmonary injury requires gamma delta T lymphocytes</article-title>. <source>J. Immunol.</source> <volume>162</volume>, <fpage>5033</fpage>&#x2013;<lpage>5036</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.162.9.5033</pub-id>, PMID: <pub-id pub-id-type="pmid">34749531</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kolls</surname> <given-names>J. K.</given-names></name>
<name><surname>Lind&#xe9;n</surname> <given-names>A.</given-names></name>
</person-group> (<year>2004</year>). 
<article-title>Interleukin-17 family members and inflammation</article-title>. <source>Immunity</source> <volume>21</volume>, <fpage>467</fpage>&#x2013;<lpage>476</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2004.08.018</pub-id>, PMID: <pub-id pub-id-type="pmid">15485625</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lebeaux</surname> <given-names>D.</given-names></name>
<name><surname>Bergeron</surname> <given-names>E.</given-names></name>
<name><surname>Berthet</surname> <given-names>J.</given-names></name>
<name><surname>Djadi-Prat</surname> <given-names>J.</given-names></name>
<name><surname>Mouni&#xe9;e</surname> <given-names>D.</given-names></name>
<name><surname>Boiron</surname> <given-names>P.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory 2010-2015</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>25</volume>, <fpage>489</fpage>&#x2013;<lpage>495</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmi.2018.06.013</pub-id>, PMID: <pub-id pub-id-type="pmid">29933049</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lederman</surname> <given-names>E. R.</given-names></name>
<name><surname>Crum</surname> <given-names>N. F.</given-names></name>
</person-group> (<year>2004</year>). 
<article-title>A case series and focused review of nocardiosis: clinical and microbiologic aspects</article-title>. <source>Med. (Baltimore)</source> <volume>83</volume>, <fpage>300</fpage>&#x2013;<lpage>313</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/01.md.0000141100.30871.39</pub-id>, PMID: <pub-id pub-id-type="pmid">15342974</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lind&#xe9;n</surname> <given-names>A.</given-names></name>
<name><surname>Laan</surname> <given-names>M.</given-names></name>
<name><surname>Anderson</surname> <given-names>G. P.</given-names></name>
</person-group> (<year>2005</year>). 
<article-title>Neutrophils, interleukin-17A and lung disease</article-title>. <source>Eur. Respir. J.</source> <volume>25</volume>, <fpage>159</fpage>&#x2013;<lpage>172</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1183/09031936.04.00032904</pub-id>, PMID: <pub-id pub-id-type="pmid">15640338</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lowman</surname> <given-names>W.</given-names></name>
<name><surname>Aithma</surname> <given-names>N.</given-names></name>
</person-group> (<year>2010</year>). 
<article-title>Antimicrobial susceptibility testing and profiling of Nocardia species and other aerobic actinomycetes from South Africa: comparative evaluation of broth microdilution versus the Etest</article-title>. <source>J. Clin. Microbiol.</source> <volume>48</volume>, <fpage>4534</fpage>&#x2013;<lpage>4540</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JCM.01073-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20980572</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Maggiorelli</surname> <given-names>C.</given-names></name>
<name><surname>Di Pierro</surname> <given-names>I.</given-names></name>
<name><surname>Manta</surname> <given-names>C.</given-names></name>
<name><surname>Maccari</surname> <given-names>U.</given-names></name>
<name><surname>Galanti</surname> <given-names>I.</given-names></name>
<name><surname>Scala</surname> <given-names>R.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>Nocardia and lungs in COPD: beyond immuno-deficiencies</article-title>. <source>COPD</source> <volume>12</volume>, <fpage>315</fpage>&#x2013;<lpage>319</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/15412555.2014.933951</pub-id>, PMID: <pub-id pub-id-type="pmid">25093624</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Markel</surname> <given-names>G.</given-names></name>
<name><surname>Bar-Haim</surname> <given-names>E.</given-names></name>
<name><surname>Zahavy</surname> <given-names>E.</given-names></name>
<name><surname>Cohen</surname> <given-names>H.</given-names></name>
<name><surname>Cohen</surname> <given-names>O.</given-names></name>
<name><surname>Shafferman</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2010</year>). 
<article-title>The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis</article-title>. <source>PloS One</source> <volume>5</volume>, <fpage>e11176</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0011176</pub-id>, PMID: <pub-id pub-id-type="pmid">20585449</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>McNeil</surname> <given-names>M. M.</given-names></name>
<name><surname>Brown</surname> <given-names>J. M.</given-names></name>
</person-group> (<year>1994</year>). 
<article-title>The medically important aerobic actinomycetes: epidemiology and microbiology</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>7</volume>, <fpage>357</fpage>&#x2013;<lpage>417</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.7.3.357</pub-id>, PMID: <pub-id pub-id-type="pmid">7923055</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Meester</surname> <given-names>I.</given-names></name>
<name><surname>Rosas-Taraco</surname> <given-names>A. G.</given-names></name>
<name><surname>Salinas-Carmona</surname> <given-names>M. C.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>Nocardia brasiliensis induces formation of foamy macrophages and dendritic cells <italic>in vitro</italic> and in <italic>vivo</italic></article-title>. <source>PloS One</source> <volume>9</volume>, <fpage>e100064</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0100064</pub-id>, PMID: <pub-id pub-id-type="pmid">24936860</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mifuji Lira</surname> <given-names>R. M.</given-names></name>
<name><surname>Lim&#xf3;n Flores</surname> <given-names>A. Y.</given-names></name>
<name><surname>Salinas Carmona</surname> <given-names>M. C.</given-names></name>
<name><surname>Ortiz Stern</surname> <given-names>A.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Experimental granulomatous pulmonary nocardiosis in BALB/C mice</article-title>. <source>PloS One</source> <volume>11</volume>, <fpage>e0157475</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0157475</pub-id>, PMID: <pub-id pub-id-type="pmid">27303806</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mikami</surname> <given-names>K.</given-names></name>
<name><surname>Sonobe</surname> <given-names>K.</given-names></name>
<name><surname>Ishino</surname> <given-names>K.</given-names></name>
<name><surname>Noda</surname> <given-names>T.</given-names></name>
<name><surname>Kato</surname> <given-names>M.</given-names></name>
<name><surname>Hanao</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Evaluation of pathogenicity and therapeutic effectiveness of antibiotics using silkworm Nocardia infection model</article-title>. <source>Drug Discov. Ther.</source> <volume>15</volume>, <fpage>73</fpage>&#x2013;<lpage>77</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5582/ddt.2021.01035</pub-id>, PMID: <pub-id pub-id-type="pmid">33952779</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Moore</surname> <given-names>T. A.</given-names></name>
<name><surname>Newstead</surname> <given-names>M. W.</given-names></name>
<name><surname>Strieter</surname> <given-names>R. M.</given-names></name>
<name><surname>Mehrad</surname> <given-names>B.</given-names></name>
<name><surname>Beaman</surname> <given-names>B. L.</given-names></name>
<name><surname>Standiford</surname> <given-names>T. J.</given-names></name>
</person-group> (<year>2000</year>). 
<article-title>Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection</article-title>. <source>J. Immunol.</source> <volume>164</volume>, <fpage>908</fpage>&#x2013;<lpage>915</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.164.2.908</pub-id>, PMID: <pub-id pub-id-type="pmid">10623839</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Navarro-Dur&#xe1;n</surname> <given-names>L. L.</given-names></name>
<name><surname>Robles-Contreras</surname> <given-names>A.</given-names></name>
<name><surname>Castrill&#xf3;n-Rivera</surname> <given-names>L. E.</given-names></name>
<name><surname>Palma-Ramos</surname> <given-names>A.</given-names></name>
<name><surname>Luna-Herrera</surname> <given-names>J.</given-names></name>
<name><surname>Casta&#xf1;eda-S&#xe1;nchez</surname> <given-names>J. I.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Nocardia brasiliensis infection induces macrophage cell death</article-title>. <source>Dermatol. Rev. Mex.</source> <volume>66</volume>, <fpage>205</fpage>&#x2013;<lpage>214</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.24245/dermatolrevmex.v66i2.7625</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Peleg</surname> <given-names>A. Y.</given-names></name>
<name><surname>Husain</surname> <given-names>S.</given-names></name>
<name><surname>Qureshi</surname> <given-names>Z. A.</given-names></name>
<name><surname>Silveira</surname> <given-names>F. P.</given-names></name>
<name><surname>Sarumi</surname> <given-names>M.</given-names></name>
<name><surname>Shutt</surname> <given-names>K. A.</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). 
<article-title>Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study</article-title>. <source>Clin. Infect. Dis.</source> <volume>44</volume>, <fpage>1307</fpage>&#x2013;<lpage>1314</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/514340</pub-id>, PMID: <pub-id pub-id-type="pmid">17443467</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Quadri</surname> <given-names>L. E.</given-names></name>
<name><surname>Sello</surname> <given-names>J.</given-names></name>
<name><surname>Keating</surname> <given-names>T. A.</given-names></name>
<name><surname>Weinreb</surname> <given-names>P. H.</given-names></name>
<name><surname>Walsh</surname> <given-names>C. T.</given-names></name>
</person-group> (<year>1998</year>). 
<article-title>Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin</article-title>. <source>Chem. Biol.</source> <volume>5</volume>, <fpage>631</fpage>&#x2013;<lpage>645</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1074-5521(98)90291-5</pub-id>, PMID: <pub-id pub-id-type="pmid">9831524</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rosas-Taraco</surname> <given-names>A. G.</given-names></name>
<name><surname>Perez-Li&#xf1;an</surname> <given-names>A. R.</given-names></name>
<name><surname>Bocanegra-Ibarias</surname> <given-names>P.</given-names></name>
<name><surname>Perez-Rivera</surname> <given-names>L. I.</given-names></name>
<name><surname>Salinas-Carmona</surname> <given-names>M. C.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Nocardia brasiliensis induces an immunosuppressive microenvironment that favors chronic infection in BALB/c mice</article-title>. <source>Infect. Immun.</source> <volume>80</volume>, <fpage>2493</fpage>&#x2013;<lpage>2499</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.06307-11</pub-id>, PMID: <pub-id pub-id-type="pmid">22547544</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Roth</surname> <given-names>A.</given-names></name>
<name><surname>Andrees</surname> <given-names>S.</given-names></name>
<name><surname>Kroppenstedt</surname> <given-names>R. M.</given-names></name>
<name><surname>Harmsen</surname> <given-names>D.</given-names></name>
<name><surname>Mauch</surname> <given-names>H.</given-names></name>
</person-group> (<year>2003</year>). 
<article-title>Phylogeny of the genus Nocardia based on reassessed 16S rRNA gene sequences reveals underspeciation and division of strains classified as Nocardia asteroides into three established species and two unnamed taxons</article-title>. <source>J. Clin. Microbiol.</source> <volume>41</volume>, <fpage>851</fpage>&#x2013;<lpage>856</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JCM.41.2.851-856.2003</pub-id>, PMID: <pub-id pub-id-type="pmid">12574299</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Salinas-Carmona</surname> <given-names>M. C.</given-names></name>
<name><surname>Longoria-Lozano</surname> <given-names>O.</given-names></name>
<name><surname>Garza-Esquivel</surname> <given-names>H. R.</given-names></name>
<name><surname>L&#xf3;pez-Ulloa</surname> <given-names>J.</given-names></name>
<name><surname>Reyes-Carrillo</surname> <given-names>J.</given-names></name>
<name><surname>V&#xe1;zquez-Marmolejo</surname> <given-names>A. V.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Inducible nitric oxide synthase blockade with aminoguanidine, protects mice infected with Nocardia brasiliensis from actinomycetoma development</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>14</volume>, <fpage>e0008775</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0008775</pub-id>, PMID: <pub-id pub-id-type="pmid">33091049</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Salinas-Carmona</surname> <given-names>M. C.</given-names></name>
<name><surname>Torres-Lopez</surname> <given-names>E.</given-names></name>
<name><surname>Ramos</surname> <given-names>A. I.</given-names></name>
<name><surname>Licon-Trillo</surname> <given-names>A.</given-names></name>
<name><surname>Gonzalez-Spencer</surname> <given-names>D.</given-names></name>
</person-group> (<year>1999</year>). 
<article-title>Immune response to Nocardia brasiliensis antigens in an experimental model of actinomycetoma in BALB/c mice</article-title>. <source>Infect. Immun.</source> <volume>67</volume>, <fpage>2428</fpage>&#x2013;<lpage>2432</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.67.5.2428-2432.1999</pub-id>, PMID: <pub-id pub-id-type="pmid">10225905</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Santos</surname> <given-names>M.</given-names></name>
<name><surname>Gil-Brusola</surname> <given-names>A.</given-names></name>
<name><surname>Morales</surname> <given-names>P.</given-names></name>
</person-group> (<year>2011</year>). 
<article-title>Infection by Nocardia in solid organ transplantation: thirty years of experience</article-title>. <source>Transplant. Proc.</source> <volume>43</volume>, <fpage>2141</fpage>&#x2013;<lpage>2144</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.transproceed.2011.06.065</pub-id>, PMID: <pub-id pub-id-type="pmid">21839216</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schulz</surname> <given-names>S. M.</given-names></name>
<name><surname>K&#xf6;hler</surname> <given-names>G.</given-names></name>
<name><surname>Holscher</surname> <given-names>C.</given-names></name>
<name><surname>Iwakura</surname> <given-names>Y.</given-names></name>
<name><surname>Alber</surname> <given-names>G.</given-names></name>
</person-group> (<year>2008</year>). 
<article-title>IL-17A is produced by Th17, gammadelta T cells and other CD4- lymphocytes during infection with Salmonella enterica serovar Enteritidis and has a mild effect in bacterial clearance</article-title>. <source>Int. Immunol.</source> <volume>20</volume>, <fpage>1129</fpage>&#x2013;<lpage>1138</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/dxn069</pub-id>, PMID: <pub-id pub-id-type="pmid">18599501</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shen</surname> <given-names>J.</given-names></name>
<name><surname>Du</surname> <given-names>B.</given-names></name>
<name><surname>Liu</surname> <given-names>Z.</given-names></name>
<name><surname>Song</surname> <given-names>Z.</given-names></name>
<name><surname>Yuan</surname> <given-names>M.</given-names></name>
<name><surname>Qiu</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Multicenter systematic review of clinical characteristics, diagnostic optimization, and personalized treatment for brain Nocardia infections</article-title>. <source>Microb. Pathog.</source> <volume>198</volume>, <elocation-id>107147</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2024.107147</pub-id>, PMID: <pub-id pub-id-type="pmid">39581236</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shen</surname> <given-names>J.</given-names></name>
<name><surname>Han</surname> <given-names>L.</given-names></name>
<name><surname>Yao</surname> <given-names>J.</given-names></name>
<name><surname>Qiu</surname> <given-names>X.</given-names></name>
<name><surname>Xu</surname> <given-names>S.</given-names></name>
<name><surname>Liu</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>a). 
<article-title>Infection route influence the consequences of Nocardia farcinica infection in BALB/c mice</article-title>. <source>BMC Infect. Dis.</source> <volume>24</volume>, <fpage>1016</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12879-024-09877-x</pub-id>, PMID: <pub-id pub-id-type="pmid">39304798</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shen</surname> <given-names>J.</given-names></name>
<name><surname>Ji</surname> <given-names>X. Z.</given-names></name>
<name><surname>Han</surname> <given-names>L.</given-names></name>
<name><surname>Yao</surname> <given-names>J.</given-names></name>
<name><surname>Liang</surname> <given-names>Y.</given-names></name>
<name><surname>Yuan</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>b). 
<article-title>Activation of NF-&#x3ba;B/MAPK signaling and induction of apoptosis by salicylate synthase NbtS in Nocardia farcinica promotes neuroinflammation development</article-title>. <source>mSystems</source> <volume>9</volume>, <fpage>e0089324</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/msystems.00893-24</pub-id>, PMID: <pub-id pub-id-type="pmid">39240104</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shibata</surname> <given-names>K.</given-names></name>
<name><surname>Yamada</surname> <given-names>H.</given-names></name>
<name><surname>Hara</surname> <given-names>H.</given-names></name>
<name><surname>Kishihara</surname> <given-names>K.</given-names></name>
<name><surname>Yoshikai</surname> <given-names>Y.</given-names></name>
</person-group> (<year>2007</year>). 
<article-title>Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production</article-title>. <source>J. Immunol.</source> <volume>178</volume>, <fpage>4466</fpage>&#x2013;<lpage>4472</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.178.7.4466</pub-id>, PMID: <pub-id pub-id-type="pmid">17372004</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname> <given-names>Z.</given-names></name>
<name><surname>Du</surname> <given-names>B.</given-names></name>
<name><surname>Yuan</surname> <given-names>M.</given-names></name>
<name><surname>Shen</surname> <given-names>J.</given-names></name>
<name><surname>Xu</surname> <given-names>S.</given-names></name>
<name><surname>Guan</surname> <given-names>W.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Genomic and phenotypic characterization of antimicrobial resistance in clinical Nocardia species isolates</article-title>. <source>Front. Cell Infect. Microbiol.</source> . doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2025.1672889</pub-id>, PMID: <pub-id pub-id-type="pmid">41050760</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Steinbrink</surname> <given-names>J.</given-names></name>
<name><surname>Leavens</surname> <given-names>J.</given-names></name>
<name><surname>Kauffman</surname> <given-names>C. A.</given-names></name>
<name><surname>Miceli</surname> <given-names>M. H.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients</article-title>. <source>Med. (Baltimore)</source> <volume>97</volume>, <fpage>e12436</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MD.0000000000012436</pub-id>, PMID: <pub-id pub-id-type="pmid">30290600</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sundararaj</surname> <given-names>T.</given-names></name>
<name><surname>Agarwal</surname> <given-names>S. C.</given-names></name>
</person-group> (<year>1978</year>). 
<article-title>Relationship of macrophages to cell-mediated immunity in experimental Nocardia asteroides infection</article-title>. <source>Infect. Immun.</source> <volume>20</volume>, <fpage>685</fpage>&#x2013;<lpage>691</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.20.3.685-691.1978</pub-id>, PMID: <pub-id pub-id-type="pmid">352953</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tam</surname> <given-names>S.</given-names></name>
<name><surname>Maksaereekul</surname> <given-names>S.</given-names></name>
<name><surname>Hyde</surname> <given-names>D. M.</given-names></name>
<name><surname>Godinez</surname> <given-names>I.</given-names></name>
<name><surname>Beaman</surname> <given-names>B. L.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>IL-17 and &#x3b3;&#x3b4; T-lymphocytes play a critical role in innate immunity against Nocardia asteroides GUH-2</article-title>. <source>Microbes Infect.</source> <volume>14</volume>, <fpage>1133</fpage>&#x2013;<lpage>1143</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micinf.2012.05.008</pub-id>, PMID: <pub-id pub-id-type="pmid">22634423</pub-id>
</mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tarchini</surname> <given-names>G.</given-names></name>
<name><surname>Ross</surname> <given-names>F. S.</given-names></name>
</person-group> (<year>2013</year>). 
<article-title>Primary lymphocutaneous nocardiosis associated with gardening: a case series</article-title>. <source>World J. Clin. Infect. Dis.</source> <volume>3</volume>, <fpage>86</fpage>&#x2013;<lpage>89</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5495/wjcid.v3.i4.86</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Torres</surname> <given-names>H. A.</given-names></name>
<name><surname>Reddy</surname> <given-names>B. T.</given-names></name>
<name><surname>Raad</surname> <given-names>I. I.</given-names></name>
<name><surname>Tarrand</surname> <given-names>J.</given-names></name>
<name><surname>Bodey</surname> <given-names>G. P.</given-names></name>
<name><surname>Hanna</surname> <given-names>H. A.</given-names></name>
<etal/>
</person-group>. (<year>2002</year>). 
<article-title>Nocardiosis in cancer patients</article-title>. <source>Med. (Baltimore)</source> <volume>81</volume>, <fpage>388</fpage>&#x2013;<lpage>397</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00005792-200209000-00004</pub-id>, PMID: <pub-id pub-id-type="pmid">12352633</pub-id>
</mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Traxler</surname> <given-names>R. M.</given-names></name>
<name><surname>Bell</surname> <given-names>M. E.</given-names></name>
<name><surname>Lasker</surname> <given-names>B.</given-names></name>
<name><surname>Headd</surname> <given-names>B.</given-names></name>
<name><surname>Shieh</surname> <given-names>W. J.</given-names></name>
<name><surname>McQuiston</surname> <given-names>J. R.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Updated review on nocardia species: 2006-2021</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>35</volume>, <fpage>e0002721</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/cmr.00027-21</pub-id>, PMID: <pub-id pub-id-type="pmid">36314911</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Trevino-Villarreal</surname> <given-names>J. H.</given-names></name>
<name><surname>Vera-Cabrera</surname> <given-names>L.</given-names></name>
<name><surname>Valero-Guill&#xe9;n</surname> <given-names>P. L.</given-names></name>
<name><surname>Salinas-Carmona</surname> <given-names>M. C.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Nocardia brasiliensis cell wall lipids modulate macrophage and dendritic responses that favor development of experimental actinomycetoma in BALB/c mice</article-title>. <source>Infect. Immun.</source> <volume>80</volume>, <fpage>3587</fpage>&#x2013;<lpage>3601</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00446-12</pub-id>, PMID: <pub-id pub-id-type="pmid">22851755</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Umemura</surname> <given-names>M.</given-names></name>
<name><surname>Yahagi</surname> <given-names>A.</given-names></name>
<name><surname>Hamada</surname> <given-names>S.</given-names></name>
<name><surname>Begum</surname> <given-names>M. D.</given-names></name>
<name><surname>Watanabe</surname> <given-names>H.</given-names></name>
<name><surname>Kawakami</surname> <given-names>K.</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). 
<article-title>IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection</article-title>. <source>J. Immunol.</source> <volume>178</volume>, <fpage>3786</fpage>&#x2013;<lpage>3796</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.178.6.3786</pub-id>, PMID: <pub-id pub-id-type="pmid">17339477</pub-id>
</mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Valdezate</surname> <given-names>S.</given-names></name>
<name><surname>Garrido</surname> <given-names>N.</given-names></name>
<name><surname>Carrasco</surname> <given-names>G.</given-names></name>
<name><surname>Medina-Pascual</surname> <given-names>M. J.</given-names></name>
<name><surname>Villal&#xf3;n</surname> <given-names>P.</given-names></name>
<name><surname>Navarro</surname> <given-names>A. M.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>72</volume>, <fpage>754</fpage>&#x2013;<lpage>761</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkw489</pub-id>, PMID: <pub-id pub-id-type="pmid">27999029</pub-id>
</mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vera-Cabrera</surname> <given-names>L.</given-names></name>
<name><surname>Ortiz-Lopez</surname> <given-names>R.</given-names></name>
<name><surname>Elizondo-Gonzalez</surname> <given-names>R.</given-names></name>
<name><surname>Ocampo-Candiani</surname> <given-names>J.</given-names></name>
</person-group> (<year>2013</year>). 
<article-title>Complete genome sequence analysis of Nocardia brasiliensis HUJEG-1 reveals a saprobic lifestyle and the genes needed for human pathogenesis</article-title>. <source>PloS One</source> <volume>8</volume>, <fpage>e65425</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0065425</pub-id>, PMID: <pub-id pub-id-type="pmid">23755230</pub-id>
</mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vuotto</surname> <given-names>F.</given-names></name>
<name><surname>Faure</surname> <given-names>K.</given-names></name>
<name><surname>Queyre</surname> <given-names>V.</given-names></name>
<name><surname>Dessein</surname> <given-names>R.</given-names></name>
<name><surname>Pasquet</surname> <given-names>A.</given-names></name>
<name><surname>Lambert</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). 
<article-title>Vascular nosocomial Nocardia farcinica infection after arterial stenting in an immunocompetent patient</article-title>. <source>Can. J. Infect. Dis. Med. Microbiol.</source> <volume>22</volume>, <fpage>e10</fpage>&#x2013;<lpage>e11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2011/216873</pub-id>, PMID: <pub-id pub-id-type="pmid">22379487</pub-id>
</mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>C.</given-names></name>
<name><surname>Sun</surname> <given-names>Q.</given-names></name>
<name><surname>Yan</surname> <given-names>J.</given-names></name>
<name><surname>Liao</surname> <given-names>X.</given-names></name>
<name><surname>Long</surname> <given-names>S.</given-names></name>
<name><surname>Zheng</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>The species distribution and antimicrobial resistance profiles of Nocardia species in China: A systematic review and meta-analysis</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>17</volume>, <fpage>e0011432</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0011432</pub-id>, PMID: <pub-id pub-id-type="pmid">37428800</pub-id>
</mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wargo</surname> <given-names>M. J.</given-names></name>
<name><surname>Gross</surname> <given-names>M. J.</given-names></name>
<name><surname>Rajamani</surname> <given-names>S.</given-names></name>
<name><surname>Allard</surname> <given-names>J. L.</given-names></name>
<name><surname>Lundblad</surname> <given-names>L. K.</given-names></name>
<name><surname>Allen</surname> <given-names>G. B.</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). 
<article-title>Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>184</volume>, <fpage>345</fpage>&#x2013;<lpage>354</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201103-0374OC</pub-id>, PMID: <pub-id pub-id-type="pmid">21562128</pub-id>
</mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wei</surname> <given-names>M.</given-names></name>
<name><surname>Xu</surname> <given-names>X.</given-names></name>
<name><surname>Yang</surname> <given-names>J.</given-names></name>
<name><surname>Wang</surname> <given-names>P.</given-names></name>
<name><surname>Liu</surname> <given-names>Y.</given-names></name>
<name><surname>Wang</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China</article-title>. <source>BMC Microbiol.</source> <volume>21</volume>, <fpage>342</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12866-021-02412-x</pub-id>, PMID: <pub-id pub-id-type="pmid">34903163</pub-id>
</mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Welsh</surname> <given-names>O.</given-names></name>
<name><surname>Morales-Toquero</surname> <given-names>A.</given-names></name>
<name><surname>Vera-Cabrera</surname> <given-names>L.</given-names></name>
<name><surname>Vazquez-Martinez</surname> <given-names>O.</given-names></name>
<name><surname>G&#xf3;mez-Flores</surname> <given-names>M.</given-names></name>
<name><surname>Ocampo-Candiani</surname> <given-names>J.</given-names></name>
</person-group> (<year>2011</year>). 
<article-title>Actinomycetoma of the scalp after a car accident</article-title>. <source>Int. J. Dermatol.</source> <volume>50</volume>, <fpage>854</fpage>&#x2013;<lpage>857</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-4632.2011.04874.x</pub-id>, PMID: <pub-id pub-id-type="pmid">21699522</pub-id>
</mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wilson</surname> <given-names>J. W.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Nocardiosis: updates and clinical overview</article-title>. <source>Mayo Clin. Proc.</source> <volume>87</volume>, <fpage>403</fpage>&#x2013;<lpage>407</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mayocp.2011.11.016</pub-id>, PMID: <pub-id pub-id-type="pmid">22469352</pub-id>
</mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Woodworth</surname> <given-names>M. H.</given-names></name>
<name><surname>Saullo</surname> <given-names>J. L.</given-names></name>
<name><surname>Lantos</surname> <given-names>P. M.</given-names></name>
<name><surname>Cox</surname> <given-names>G. M.</given-names></name>
<name><surname>Stout</surname> <given-names>J. E.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>Increasing nocardia incidence associated with bronchiectasis at a tertiary care center</article-title>. <source>Ann. Am. Thorac. Soc</source> <volume>14</volume>, <fpage>347</fpage>&#x2013;<lpage>354</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1513/AnnalsATS.201611-907OC</pub-id>, PMID: <pub-id pub-id-type="pmid">28231023</pub-id>
</mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xia</surname> <given-names>L.</given-names></name>
<name><surname>Liang</surname> <given-names>H.</given-names></name>
<name><surname>Xu</surname> <given-names>L.</given-names></name>
<name><surname>Chen</surname> <given-names>J.</given-names></name>
<name><surname>Bekaert</surname> <given-names>M.</given-names></name>
<name><surname>Zhang</surname> <given-names>H.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Subcellular localization and function study of a secreted phospholipase C from Nocardia seriolae</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>364</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/femsle/fnx143</pub-id>, PMID: <pub-id pub-id-type="pmid">28911184</pub-id>
</mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yao</surname> <given-names>J.</given-names></name>
<name><surname>Han</surname> <given-names>L.</given-names></name>
<name><surname>Shen</surname> <given-names>J.</given-names></name>
<name><surname>Du</surname> <given-names>B.</given-names></name>
<name><surname>Song</surname> <given-names>Z.</given-names></name>
<name><surname>Yuan</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Nitric oxide contributes to the pathogenesis of nocardia farcinica infection in BALB/c mice and alveolar MH-S macrophages</article-title>. <source>Microorganisms</source> <volume>13</volume>, <elocation-id>2336</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms13102336</pub-id>, PMID: <pub-id pub-id-type="pmid">41156795</pub-id>
</mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yeoh</surname> <given-names>K.</given-names></name>
<name><surname>Globan</surname> <given-names>M.</given-names></name>
<name><surname>Naimo</surname> <given-names>P.</given-names></name>
<name><surname>Williamson</surname> <given-names>D. A.</given-names></name>
<name><surname>Lea</surname> <given-names>K.</given-names></name>
<name><surname>Bond</surname> <given-names>K.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Identification and antimicrobial susceptibility of referred Nocardia isolates in Victoria, Australia 2009-2019</article-title>. <source>J. Med. Microbiol.</source> <volume>71</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/jmm.0.001581</pub-id>, PMID: <pub-id pub-id-type="pmid">35976092</pub-id>
</mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yong</surname> <given-names>E. X.</given-names></name>
<name><surname>Cheong</surname> <given-names>E. Y.</given-names></name>
<name><surname>Boutlis</surname> <given-names>C. S.</given-names></name>
<name><surname>Chen</surname> <given-names>D. B.</given-names></name>
<name><surname>Liu</surname> <given-names>E. Y.</given-names></name>
<name><surname>McKew</surname> <given-names>G. L.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>Nocardia septic arthritis complicating an anterior cruciate ligament repair</article-title>. <source>J. Clin. Microbiol.</source> <volume>53</volume>, <fpage>2760</fpage>&#x2013;<lpage>2762</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JCM.00754-15</pub-id>, PMID: <pub-id pub-id-type="pmid">26041900</pub-id>
</mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zoropogui</surname> <given-names>A.</given-names></name>
<name><surname>Pujic</surname> <given-names>P.</given-names></name>
<name><surname>Normand</surname> <given-names>P.</given-names></name>
<name><surname>Barbe</surname> <given-names>V.</given-names></name>
<name><surname>Belli</surname> <given-names>P.</given-names></name>
<name><surname>Graindorge</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2013</year>). 
<article-title>The Nocardia cyriacigeorgica GUH-2 genome shows ongoing adaptation of an environmental Actinobacteria to a pathogen&#x2019;s lifestyle</article-title>. <source>BMC Genomics</source> <volume>14</volume>, <elocation-id>286</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2164-14-286</pub-id>, PMID: <pub-id pub-id-type="pmid">23622346</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1337792">Percy Schr&#xf6;ttner</ext-link>, Technische Universit&#xe4;t Dresden, Germany</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1375290">Lucio Vera-Cabrera</ext-link>, Universidad Autonoma de Nuevo Le&#xf3;n, Mexico</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/16116">Luiz Bermudez</ext-link>, Oregon State University, United States</p></fn>
</fn-group>
</back>
</article>